Sterile Medical Pen Manufacturing & Packaging

The contract involves the manufacture and packaging of sterile, disposable skin-marking pens featuring an integrated ruler and gentian violet ink, designed for medical use and required to meet stringent FDA and Department of Defense standards. Each pen must be individually sealed to ensure sterility and compliance with regulatory requirements for safe deployment in clinical and field environments. The product is intended for use in surgical and medical settings where precise skin marking is critical, and the integrated ruler enhances accuracy during procedural preparation. Performance is to be carried out at GROTON, Connecticut, with a response deadline of July 27, 2026, and the contract type is classified as a subcontract under NAICS code 325414, which pertains to medicinal and botanical manufacturing. The overseeing agency is the Department of Defense through the Medical Supply Chain MD Surg FSF, indicating this is part of a broader DoD medical procurement initiative. While no specific set-aside details are provided, the requirement emphasizes adherence to federal quality and safety benchmarks, and bidders must be prepared to demonstrate capability in sterile manufacturing, packaging integrity, and full compliance with military medical supply protocols.